Arasan furthers MIPI I3C® compliance with its participation at the I3C® interop in TaipeiSeptember 10, 2026
Airway Therapeutics Closes $50 Million Equity Round to Advance Late-Stage Development of Zelpultide Alfa PR Newswire August 25, 2026 The capital raise supports ongoing Phase 2b/3 clinical trial for prevention of bronchopulmonary dysplasia and associated CMC and analytical activitiesApproximately…
